Cleveland, OH, United States of America

Stephen P Davanzo

This inventor holds 1 USPTO granted patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen P Davanzo. Retrieved from https://idiyas.com/inventor/stephen-p-davanzo-wfxgpes0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen P. Davanzo

Introduction

Stephen P. Davanzo is an accomplished inventor based in Cleveland, OH. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of micronized particles of antimuscarinic compounds. His innovative work has led to advancements in drug formulation and stability.

Latest Patents

Stephen P. Davanzo holds a patent for the "Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation." This patent describes a method for creating crystalline micronized particulate of a glycopyrronium salt through hydrodynamic cavitation. The resulting drug particles are noted for their physical stability concerning agglomeration and/or aggregation during storage. He has 1 patent to his name.

Career Highlights

Davanzo is currently employed at Chiesi Farmaceutici S.p.a., where he continues to innovate in the pharmaceutical industry. His work focuses on enhancing drug delivery systems and improving the efficacy of medications.

Collaborations

Throughout his career, Stephen has collaborated with notable colleagues, including Barry E. Nall and Michele Miozzi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Stephen P. Davanzo's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in drug formulation. His work continues to influence the industry and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…